Skip to main content
. Author manuscript; available in PMC: 2022 Dec 5.
Published in final edited form as: J Neurooncol. 2021 Sep 7;155(1):25–34. doi: 10.1007/s11060-021-03839-y

Table 1.

Feasibility and acceptability evaluation metrics

Domain Metric
Safety • Adverse event reporting
Recruitment feasibility • Eligibility rate
• Rates and reasons for ineligibility
• Eligibility based on objective v. subjective working memory impairment
• Enrollment rate
Acceptability of procedures • Retention rates of the intention-to-treat sample, ≥70% was deemed acceptable
• Differences in demographic, medical, and baseline measures between treatment completers and dropouts
Intervention acceptability • Retention rates of treatment initiators, ≥70% was deemed acceptable
• Reason for dropouts
• Per protocol intervention adherence, completing 5 sessions per week for 5 weeks
• Reported challenges/diffculties throughout the intervention
• Intervention satisfaction survey